✦ LIBER ✦

Over 2-year disease-free survival after multimodality therapy of a primary cardiac lymphoma

✍ Scribed by Michael Ried; Stephan Hirt; Christof Schmid

Book ID: 116523623
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 116 KB
Volume: 31
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2011.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of anaplastic thyroid carcinoma s

A case of anaplastic thyroid carcinoma surviving disease free for over 2 years

✍ Takayuki Kanaseki; Yasuaki Harabuchi; Junichi Wakashima; Koji Asakura; Akikatsu 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 861 KB

A patient with bilateral primary adrenal

A patient with bilateral primary adrenal lymphoma, presenting with fever of unknown origin and achieving long-term disease-free survival after resection and chemotherapy

✍ H.-C. Wu; L.-Y. Shih; T.-C. Chen; S.-H. Chu; C.-C. Tsai 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 554 KB

Switching to exemestane after 2–3 years

Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.

✍ Christina Davies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB

External validation of disease-free surv

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

✍ P. Nuhn; M. May; H.-M. Fritsche; A. Buchner; S. Brookman-May; C. Bolenz; R. Mori 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Neoadjuvant Therapy Protocol and Liver T

Neoadjuvant Therapy Protocol and Liver Transplantation in Combination With Pancreatoduodenectomy for the Treatment of Hilar Cholangiocarcinoma Occurring in a Case of Primary Sclerosing Cholangitis: Case Report With a More Than 8-Year Disease-Free Survival

✍ E. Gringeri; D. Bassi; F.E. D'Amico; R. Boetto; M. Polacco; E. Lodo; F. D'Amico; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB

530 EXTERNAL VALIDATION OF DISEASE-FREE

530 EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER

✍ Bastian, Patrick J.; May, Matthias; Fritsche, Hans-Martin; Buchner, Alexander; B 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 179 KB